Publications:

Genomic landscape and efficacy of HER2-targeted therapy in patients with HER2-mutant non-small cell lung cancer.

Frontiers In Oncology

Han, Yanjie Y; Xiong, Yuanyuan Y; Lu, Tao T; Chen, Rongrong R; Liu, Yuan Y; Tang, Hui H; Geng, Ruixuan R; Wang, Yingyi Y

Publication Date: 2023

Variant appearance in text: HER2: L494F

PubMed Link: 37077822

Variant Present in the following documents:

• fonc-13-1121708.pdf

View BVdb publication page

A novel, somatic, transforming mutation in the extracellular domain of Epidermal Growth Factor Receptor identified in myeloproliferative neoplasm.

Scientific Reports

Casolari, D A DA; Nguyen, T T; Butcher, C M CM; Iarossi, D G DG; Hahn, C N CN; Bray, S C SC; Neufing, P P; Parker, W T WT; Feng, J J; Maung, K Z Y KZY; Wee, A A; Vidovic, L L; Kok, C H CH; Bardy, P G PG; Branford, S S; Lewis, I D ID; Lane, S W SW; Scott, H S HS; Ross, D M DM; D'Andrea, R J RJ

Publication Date: 2017-05-26

Variant appearance in text: ERBB2: L494F

PubMed Link: 28550306

Variant Present in the following documents:

• Main text
• 41598_2017_Article_2655.pdf

View BVdb publication page

Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms.

Leukemia

Tenedini, E E; Bernardis, I I; Artusi, V V; Artuso, L L; Roncaglia, E E; Guglielmelli, P P; Pieri, L L; Bogani, C C; Biamonte, F F; Rotunno, G G; Mannarelli, C C; Bianchi, E E; Pancrazzi, A A; Fanelli, T T; Malagoli Tagliazucchi, G G; Ferrari, S S; Manfredini, R R; Vannucchi, A M AM; Tagliafico, E E; ,

Publication Date: 2014-05

Variant appearance in text: ERBB2: L494F

PubMed Link: 24150215

Variant Present in the following documents:

• leu2013302x7.xls, sheet 1

View BVdb publication page